ENTITY
Ascentage Pharma Group Corp

Ascentage Pharma Group Corp (6855 HK)

35
Analysis
Health CareChina
Ascentage Pharma Group International operates as a clinical-stage biotechnology company. The Company develops novel therapies for cancers, hepatitis B virus, age-related diseases, and more. Ascentage Pharma Group International conducts businesses in China, the United States, and other countries.
more
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x